1Short AK,Zhao MH, Lockwood CM. Autoantibodies:their usefulness in distinguishing different forms of vasculitis, International Yearbook of Nephrology Transplantation[J]. Nephrol Dialy Transplant, 1995,10(Suppl) :61.
2Zhao MH,Lockwood CM. ANCA defienes clinical disease manifestations of vasculitis[ J ]. Sarcoidosis Vasculitis and Diffuse Lung Disease, 1996,13 ( 3 ) :221-226.
3Zhao MH,Lockwood CM. Azurocidin is a novel antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in systemic vascutilis [J]. Clin Exp lmmunol, 1996,103(3):397-402.
4Choi HK,Merkel PA,Walker AM,et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies[J]. Arthritis Rheum,2000,43 ( 2 ) :405 -413.
3Jennette JC, Falk R J, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum, 1994,37(2) : 187-192.
4Harper L, CockweU P, Savage CO. Case of propyithiouracii-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant, 1998,13(2) :455-458.
5Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet, 1993,342 (8872) :6514552.
